Ole-Erik Iversen

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Warner K. Huh, Elmar A. Joura, Anna R. Giuliano et al. · The Lancet · 2017 · 459 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

Sven-Eric Olsson, Susanne K. Kjær, Kristján Sigurðsson et al. · Human Vaccines · 2009 · 218 citations · Full text

Medicine, Immunology, Preventive Medicine +17

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

Elmar A. Joura, Susanne K. Kjær, Cosette M. Wheeler et al. · Vaccine · 2008 · 196 citations · Full text

Veterinary Medicine, Immunology, Preventive Medicine +16

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Elmar A. Joura, Kevin A. Ault, F. Xavier Bosch et al. · Cancer Epidemiology Biomarkers & Prevention · 2014 · 180 citations · Full text

Medicine, Gynecology, Oncology +17

Long-term Study of a Quadrivalent Human Papillomavirus Vaccine

Daron Ferris, Rudiwilai Samakoses, Stan L. Block et al. · PEDIATRICS · 2014 · 104 citations

Veterinary Medicine, Immunology, Infectious Diseases +17